The actions of three immunosuppressive drugs on normal antibody synthesis in the adult mouse were determined. Inbred mice were given daily intraperitoneal injections of actinomycin D, uracil mustard, or cyclophosphamide for extended periods. The sera of treated and untreated mice were assayed for phage-neutralizing activity to monitor the effect of each drug on the amount of circulating normal antibody. Except for an initial decrease in titer of normal anti-phage MSP2 activity, actinomycin D had no significant effect on normal antibody activity. Uracil mustard caused alternating elevation and depression of normal antibody titers. Cyclophosphamide caused a prolonged depression of normal antibody. The response patterns to the three immunosuppressive agents were the same for both induced and normal antibody.
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Suppression of the induced immune response has been demonstrated with a wide variety of chemical agents having diverse metabolic effects. Accordingly, selected immunosuppressive agents can be used as tools for studies on the biosynthesis of normal antibodies. If normal antibody is produced by the same mechanism as induced antibody, then it should be possible to decrease the amount of circulating normal antibody in an animal with immunosuppressive agents. Muschel, Jackson, and Schmoker (13) treated rabbits with actinomycin D and reported no change in the normal antibody activity directed against ovalbumin. Brooke (4) reported no change in the concentration of normal antibody in the serum of mice treated with 6-mercaptopurine. Michael, Whitby, and Landy (11) and Brooke (4) , in independent studies, subjected mice to whole body X-irradiation. Neither group observed any effects upon the normal antibody content in the sera of the tested mice. All of these experiments were of short duration; therefore, they may not constitute an adequate evaluation of the effects of immunosuppressive agents on normal antibody synthesis. Komfeld and Miller (9) also subjected mice to whole body irradiation, however, these investigators continued to assay serum samples of their animals for 28 days after treatment. It was observed that the mean titers of sera from individual mice declined steadily for 10 random, anesthetized with diethylether, and bled through the retino-orbital sinus with sterile micropipettes. The blood from the mice in each group was pooled and allowed to clot. The clot was removed, and the sera were centrifuged at 3,500 X g for 15 min. The clear serum was collected and stored at 4 C until it was used.
The serum samples were assayed for antibody activity by a modification of the phage neutralization assay described by Bradley and Watson (3) . All sera were heated at 56 C for 30 min, and all dilutions were made in sterile peptone-yeast extract broth (5 g water). For the assay, the diluted serum was mixed with actinophage MSP2 to give 105 plaque-forming units/ml, and was incubated at 30 C. The incubation time and serum dilution were dependent upon the neutralizing activity of the serum. Normal sera were usually diluted 1:3 and 1:10, and the phage neutralization mixtures were sampled after 30 and 90 min of incubation. Each sample was immediately diluted 1:100 in cold peptone-yeast extract broth to prevent further neutralization of the phage, and 0.1 ml of the diluted reaction mixture was added to 2.5 ml of molten peptone-yeast extract-2% agar. Then 2.0 ml of a Streptomyces venezuelae spore suspension, sufficient to give confluent growth, was added to the above mixture. The inoculated semisolid agar was poured onto a peptone-yeast agar base layer. The actinophage cultures were incubated overnight at 30 C. Duplicate plates were made for plaque counts.
The three antitumor agents used in this study were cyclophosphamide (Cytoxan; Mead Johnson Laboratories, Evansville, Ind.), 5-bis-(2'-chloroethyl)-aminouracil (uracil mustard; The Upjohn Co., Kalamazoo, Mich.), and actinomycin D (Merck Sharp and Dohme Research Laboratories, Rahway, N.J.).
RESULTS
Actinomycin D. Actinomycin D has not been found to be an effective inhibitor of the induced immune response by a number of investigators (6, 7, 14) . In fact, actinomycin D only delays the onset of the immune response for a short period of time and does not have any effect on the maximal titer of antibody against the injected antigen. In our own experiments on the induced immune response, actinomycin D was injected into different groups of animals at doses of 3, 5, or 7 ,ug per day for 4 consecutive days. The mice had been stimulated with a single injection of 1010 actinophage MSP2 on day 1. The induced antibody titer was suppressed by 80% on day 5 when animals were treated with 5 jug of actinomycin D per day.
To determine the effect of actinomycin D on normal antibody synthesis, test animals were given daily intraperitoneal injections of 5 ,ug of actinomycin D for 28 consecutive days. The initial effect of actinomycin D was to depress the titer of normal antibody against actinophage MSP2 (Fig. 1) . Throughout the majority of the experimental period, however, the drug did not exert any significant effect on the concentration of circulating normal antibody. This experiment was terminated on day 29 because the sole remaining mouse was moribund. Of 63 animals treated with actinomycin D. 20 died; therefore, in our experiments on normal antibody, we found toxicity to be a serious limiting factor.
Uracil mustard. Initially, uracil mustard caused a slight decrease in the titer of normal antibody to actinophage MSP2 (Fig. 2) . The decrease was then followed by a marked rise in normal anti-phage MSP2 antibody. The apparent stimulation was then SUPPRESSION OF NORMAL ANTIBODY followed by a depression in circulating antibody, which was succeeded by another rise in titer, although this peak was not as high as the first "'stimulation" peak.
Cyclophosphamide. Cyclophosphamide, when injected along with, or after, antigen, causes a long-lasting suppression of the induced immune response (1, 10) . A number of studies have shown -that this drug first acts, in an undefined way, by killing a large proportion of the lymphoid population (1, 2, 8, 12 ) and causes a profound depression -of deoxyribonucleic acid synthesis in those cells which survive the initial injury (1). Thus, cyclophosphamide not only interferes with the initiation of cellular events which occur in an immune response, but it is also able to disrupt the process once it has begun. Our own experiments support these observations. Mice were given daily intraperitoneal injections of cyclophosphamide in a dose of 1 mg per day, and they received a single injection of 1010 actinophage MSP2 on day 1. Throughout the 17-day experiment, cyclophosphamide produced a profound depression of anti-MSP2 antibody.
To determine the action of cyclophosphamide on normal antibody synthesis, the drug was administered daily to test animals by intraperitoneal injection, in a dose of 1 mg for 20 consecutive days. Cyclophosphamide also exerted a significant effect on the activity of circulating normal antibody against actinophage MSP2 * (Fig. 3) . However, unlike uracil mustard, cyclo- Actmomycin D has been used as a model to determine whether the system that produces normal antibody is the same as the system that produces induced antibody. Muschel, Jackson, and Schmoker (13) Our own experiments demonstrate that the response patterns to the three immunosuppressive agents under study were the same for both induced and normal antibody. Uracil mustard, a short-term inhibitor of the induced immune response, does not cause a long-lasting depression of normal antibody below the control base line. Cyclophosphamide, which strongly suppresses the induced immune response, also causes a significant, protracted inhibition of normal antibody. Therefore, it seems that there is nothing unique about the synthesis of normal antibody compared to that of induced antibody in the mouse.
